Neurones (FR:NRO)
:NRO
France Market
Advertisement

Neurones (NRO) Ratios

Compare
5 Followers

Neurones Ratios

FR:NRO's free cash flow for Q2 2025 was €1.00. For the 2025 fiscal year, FR:NRO's free cash flow was decreased by € and operating cash flow was €0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.31 2.38 2.45 2.51 2.78
Quick Ratio
2.31 2.38 2.44 2.51 2.77
Cash Ratio
1.16 1.30 0.37 0.52 0.89
Solvency Ratio
0.21 0.25 0.25 0.24 0.24
Operating Cash Flow Ratio
0.36 0.31 0.27 0.35 0.43
Short-Term Operating Cash Flow Coverage
7.54 12.35 361.43 315.53 260.34
Net Current Asset Value
€ 288.60M€ 279.47M€ 265.41M€ 249.22M€ 258.24M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.07 0.06 0.06 0.06
Debt-to-Equity Ratio
0.11 0.12 0.11 0.11 0.11
Debt-to-Capital Ratio
0.10 0.11 0.10 0.10 0.10
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.93 1.90 1.86 1.82 1.70
Debt Service Coverage Ratio
4.30 10.24 36.73 50.14 39.72
Interest Coverage Ratio
36.90 52.90 41.14 62.60 50.04
Debt to Market Cap
0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
1.79 1.87 1.56 1.50 1.45
Net Debt to EBITDA
-3.00 -2.63 -0.46 -0.79 -1.59
Profitability Margins
Gross Profit Margin
74.40%46.78%12.27%12.03%13.08%
EBIT Margin
8.89%10.89%11.02%10.82%10.25%
EBITDA Margin
9.89%13.04%13.33%13.15%13.11%
Operating Profit Margin
8.89%10.23%10.66%10.43%9.73%
Pretax Profit Margin
10.12%10.90%10.76%10.43%10.05%
Net Profit Margin
6.09%6.67%6.65%6.50%5.89%
Continuous Operations Profit Margin
7.31%7.90%7.78%7.40%6.67%
Net Income Per EBT
60.20%61.18%61.80%62.36%58.63%
EBT Per EBIT
113.89%106.47%100.94%99.99%103.31%
Return on Assets (ROA)
7.06%7.33%7.17%6.64%5.62%
Return on Equity (ROE)
13.53%13.94%13.36%12.10%9.58%
Return on Capital Employed (ROCE)
15.76%17.03%17.29%15.78%13.14%
Return on Invested Capital (ROIC)
11.10%12.00%12.26%10.99%8.57%
Return on Tangible Assets
7.74%7.95%8.41%7.90%6.66%
Earnings Yield
4.90%4.73%4.65%4.10%5.45%
Efficiency Ratios
Receivables Turnover
3.12 3.57 2.97 3.52 3.01
Payables Turnover
10.04 8.96 13.60 13.52 13.96
Inventory Turnover
99.58K 556.30 590.24 333.65 348.80
Fixed Asset Turnover
13.42 12.62 13.36 12.58 11.24
Asset Turnover
1.16 1.10 1.08 1.02 0.95
Working Capital Turnover Ratio
2.52 2.41 2.30 2.04 1.93
Cash Conversion Cycle
80.60 62.10 96.63 77.73 96.24
Days of Sales Outstanding
116.95 102.20 122.85 103.63 121.34
Days of Inventory Outstanding
<0.01 0.66 0.62 1.09 1.05
Days of Payables Outstanding
36.35 40.76 26.84 26.99 26.15
Operating Cycle
116.95 102.86 123.47 104.72 122.38
Cash Flow Ratios
Operating Cash Flow Per Share
3.63 2.97 2.27 2.67 2.85
Free Cash Flow Per Share
3.16 2.23 1.83 2.40 2.55
CapEx Per Share
0.48 0.74 0.44 0.27 0.30
Free Cash Flow to Operating Cash Flow
0.87 0.75 0.81 0.90 0.90
Dividend Paid and CapEx Coverage Ratio
2.04 1.61 1.58 1.18 5.73
Capital Expenditure Coverage Ratio
7.61 4.01 5.18 9.83 9.59
Operating Cash Flow Coverage Ratio
2.13 1.64 1.52 1.83 2.02
Operating Cash Flow to Sales Ratio
0.11 0.10 0.08 0.11 0.13
Free Cash Flow Yield
7.40%5.18%4.66%6.31%10.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.40 21.14 21.49 24.40 18.35
Price-to-Sales (P/S) Ratio
1.24 1.41 1.43 1.59 1.08
Price-to-Book (P/B) Ratio
2.79 2.95 2.87 2.95 1.76
Price-to-Free Cash Flow (P/FCF) Ratio
13.52 19.31 21.45 15.84 9.18
Price-to-Operating Cash Flow Ratio
11.73 14.49 17.31 14.23 8.22
Price-to-Earnings Growth (PEG) Ratio
-5.53 1.93 1.24 1.12 23.30
Price-to-Fair Value
2.79 2.95 2.87 2.95 1.76
Enterprise Value Multiple
9.59 8.18 10.26 11.28 6.66
Enterprise Value
788.73M 790.88M 910.14M 859.95M 457.89M
EV to EBITDA
9.59 8.18 10.26 11.28 6.66
EV to Sales
0.95 1.07 1.37 1.48 0.87
EV to Free Cash Flow
10.29 14.62 20.53 14.80 7.41
EV to Operating Cash Flow
8.94 10.97 16.57 13.29 6.64
Tangible Book Value Per Share
15.21 14.65 11.76 10.85 11.27
Shareholders’ Equity Per Share
15.29 14.62 13.67 12.87 13.31
Tax and Other Ratios
Effective Tax Rate
0.28 0.27 0.28 0.29 0.34
Revenue Per Share
34.28 30.58 27.47 23.95 21.64
Net Income Per Share
2.09 2.04 1.83 1.56 1.28
Tax Burden
0.60 0.61 0.62 0.62 0.59
Interest Burden
1.14 1.00 0.98 0.96 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.29 0.29
Stock-Based Compensation to Revenue
>-0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.74 1.23 1.24 1.72 2.23
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis